Report Categories
View AllRecent Articles
View All
Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation
QUMS Quantumsphere Acquisition publishes latest quarterly earnings management to outline core strategic priorities for coming fiscal year
Target Corporation TGT Unveils New Chapter Growth Plan Leveraging Fandom Partnerships and Wellness Category Expansion
Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia